Proteros biostructures
Latest round
- Series B
Last raised
- Aug 2007
Total raised
- $7.4M
Investors
- 1
About Proteros biostructures
Founded in 2000 and based in Germany, Proteros biostructures GmbH specializing in early drug discovery, focusing on complex biologics and protein therapeutics through advanced structural biology techniques. Proteros biostructures GmbH provides early-stage drug discovery services, assisting pharmaceutical and biotechnology companies in understanding complex biologic targets. In February 2023, Inflexion Private Equity Partners acquired a minority stake in Proteros biostructures GmbH from BayBG. Proteros specializes in early drug discovery services, focusing on the development of complex biologics and protein-based therapeutics. The company’s core offerings include elucidation of intricate protein structures, high-resolution protein crystallography, and cryo-electron microscopy (cryo-EM). Proteros assists clients in accessing challenging drug targets, including multi-subunit protein complexes and membrane-associated proteins, critical for innovative drug discovery. Their proprietary technology platform allows for customized assays, including binding, kinetics, and biochemical profiling, tailored to client needs.Proteros operates within a business-to-business model, primarily serving pharmaceutical and biotech firms seeking advanced drug discovery solutions.
Who invested in Proteros biostructures
1 investor across 1 round
See all investors in Proteros biostructures
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 22, 2007
Amount
$7.4M
Investors
Questions about Proteros biostructures
Who invested in Proteros biostructures?
Proteros biostructures has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteros biostructures raised?
Proteros biostructures has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proteros biostructures last raise money?
Proteros biostructures's most recent round on record is a Series B, in Aug 2007.
What does Proteros biostructures do?
Founded in 2000 and based in Germany, Proteros biostructures GmbH specializing in early drug discovery, focusing on complex biologics and protein therapeutics through advanced structural biology techniques.
Where is Proteros biostructures headquartered?
Proteros biostructures is headquartered in Germany.
Which VCs invest in companies like Proteros biostructures?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Proteros biostructures's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Proteros biostructures? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.